US Companies Moving the Markets, Evening edition
Wed, Apr 24, 2024 as of 4:00 pm ET

Stock Information for Genenta Science S.p.A.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Genenta Science S.p.A.

Cidara Announces Proposed Public Offering of Common Stock
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza
Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development
Cidara Therapeutics to Participate in The Citizens Life Sciences Conference
Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.